REFERENCES
- Apodaca G. The uroepithelium: Not just a passive barrier. Traffic 2004; 5(3)117–128
- Burtis C. A., Ashwood E. R. Tietz textbook of clinical chemistry. WB Saunders, Philadelphia 1986
- Chancellor M. B., Yoshimura N. Treatment of interstitial cystitis. Urology 2004; 63(3 Suppl. 1)85–92
- Dodane V., Khan M. A., Merwin J. R. Effect of chitosan on epithelial permeability and structure. Int. J. Pharm. 1999; 182: 21–32
- Gill W. B., Jones K. W., Ruggiero K. J. Protective effects of heparin and other sulfated glycosaminoglycans on crystal adhesion to injured urothelium. J. Urol. 1982; 127: 152–154
- Hanno P. M., Fritz R., Wein A. J., Mulholland S. G. Heparin as antibacterial agent in rabbit bladder. Urology 1978; 12(4)411–415
- Hurst R. E., Zebrowski R. Identification of proteoglycans present at high density on bovine and human bladder luminal surface. J. Urol. 1994; 152: 1641–1645
- Kerec M., Bogataj M., Veranic P., Mrhar A. Permeability of pig urinary bladder wall: The effect of chitosan and the role of calcium. Eur. J. Pharm. Sci. 2005; 25(1)113–121
- Kerec Kos M., Bogataj M., Veranic P., Mrhar A. Permeability of pig urinary bladder wall: Time and concentration dependent effect of chitosan. Biol. Pharm. Bull. 2006; 29(8)1685–1691
- Lewis S. A. Everything you wanted to know about the bladder epithelium but were afraid to ask. Am. J. Physiol. Renal Physiol. 2000; 278: 867–874
- Lilly J. D., Parsons C. L. Bladder surface glycosaminoglycans is a human epithelial permeability barrier. Surg. Gynecol. Obstet. 1990; 171: 493–496
- Lothar T. Clinical laboratory diagnostics: Use and assessment of clinical laboratory results. TH-Books, FrankfurtGermany 1998
- Nickel J. C., Downey J., Morales A., Emerson L., Clark J. Relative efficacy of various exogenous glycosaminoglycans in providing a bladder surface permeability barrier. J. Urol. 1998; 160(2)612–614
- Parsons C. L. Epithelial coating techniques in the treatment of interstitial cystitis. Urology 1997; 45: 100–104
- Parsons C. L., Boychuk D., Jones S., Hurst R., Callahan H. Bladder surface glyosaminoglycans: an epithelial permeability barrier. J. Urol. 1990; 143(1)139–142
- Ruggieri M. R., Hanno P. M., Levin R. M. The effects of heparin on the adherence of five species of urinary tract pathogens to urinary bladder mucosa. Urol. Res. 1984; 12(4)199–203
- Schipper N. G. M., Olsson S., Hoogstraate J. A., de Boer A. G., Vårum K. M., Artursson P. Chitosans as absorption enhancers for poorly absorbable drugs 2: Mechanism of absorption enhancement. Pharm. Res. 1997; 14(7)923–929
- Smith C. L. Calcium oxalate crystal adherence in the rat bladder: Restoration of anti-adherence after acid treatment. J. Urol. 2004; 171(2 Pt 1)882–884
- Smith J., Wood E., Dornish M. Effect of chitosan on epithelial cell tight junctions. Pharm. Res. 2004; 21(1)43–49